Targeting Antibiotic Resistance

Angew Chem Int Ed Engl. 2016 Jun 1;55(23):6600-26. doi: 10.1002/anie.201506818. Epub 2016 Mar 22.

Abstract

Finding strategies against the development of antibiotic resistance is a major global challenge for the life sciences community and for public health. The past decades have seen a dramatic worldwide increase in human-pathogenic bacteria that are resistant to one or multiple antibiotics. More and more infections caused by resistant microorganisms fail to respond to conventional treatment, and in some cases, even last-resort antibiotics have lost their power. In addition, industry pipelines for the development of novel antibiotics have run dry over the past decades. A recent world health day by the World Health Organization titled "Combat drug resistance: no action today means no cure tomorrow" triggered an increase in research activity, and several promising strategies have been developed to restore treatment options against infections by resistant bacterial pathogens.

Keywords: antibiotic resistance; antibiotics; drug design; medicinal chemistry; structure-activity relationships.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology*
  • Bacteria / metabolism
  • Bacterial Proteins / antagonists & inhibitors
  • Bacterial Proteins / biosynthesis
  • Drug Design
  • Drug Resistance, Multiple, Bacterial / drug effects*
  • Macrolides / chemistry
  • Macrolides / pharmacology
  • Molecular Dynamics Simulation
  • Organophosphates / chemistry
  • Organophosphates / pharmacology
  • Oxazoles / chemistry
  • Oxazoles / pharmacology
  • Oxazolidinones / chemistry
  • Oxazolidinones / pharmacology
  • Structure-Activity Relationship

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Macrolides
  • Organophosphates
  • Oxazoles
  • Oxazolidinones
  • tedizolid phosphate